Herbert J. Faleck, D.O.
Dr. Herbert J. Faleck has been the Chief Medical Officer of Edge Therapeutics, Inc. since 2013. He is a pediatric neurologist trained at the Cleveland Clinic and has more than 25 years of extensive and successful experience in clinical research and development in the pharmaceutical and biotechnology industries.
Prior to joining Edge, Dr. Faleck was with Celgene Corporation for over 9 years. At Celgene, he served in several roles including the Chief Medical Officer position at Celgene Cellular Therapeutics, where he led the clinical, medical, regulatory and organizational development for a key division of the company. He was also Celgene’s first Vice President of Clinical Research and Development building the Clinical R&D group and leading programs that resulted in the approvals of several of the company’s key drugs. Previously, he held positions of increasing responsibility at Novartis Pharmaceuticals.
Dr. Faleck received his medical degree from The University of Health Sciences College of Osteopathic Medicine in Kansas City, Missouri.